CereSpir's itanapraced reduces neurotoxicity in PD model

CereSpir Inc. (New York, N.Y.) reported on Dec. 10 that lead product itanapraced

Read the full 139 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE